Iroko Pharmaceuticals

Iroko Pharmaceuticals, LLC is a specialty pharmaceutical company based in Philadelphia, Pennsylvania, focused on developing and commercializing innovative pharmaceutical products for pain management. Founded in 2007, the company markets a range of prescription pain medications, including Indocid, Aldomet, TIVORBEX, ZORVOLEX, and VIVLODEX, which are designed to address various pain management needs, particularly for patients with osteoarthritis and acute pain. Iroko utilizes proprietary technology to formulate lower-dose nonsteroidal anti-inflammatory drugs (NSAIDs), improving therapeutic options for patients. The company has established a robust distribution and sales network, extending its reach to more than 40 countries, and aims to enhance healthcare by revitalizing existing medications through new applications and geographic markets.